Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

Traders are suddenly stampeding these Buffett stocks: https://www.marketbeat.com/logos/articles/med_20240102191321_traders-are-suddenly-stampeding-these-buffett-stoc.jpg
Traders are suddenly stampeding these Buffett stocks

The new year is here, and some are already calling the shots about how 2024 could look. Who dominates? It will likely experience a 'trader' market in the first quarter of 2024, considering where

AT&T could be the best placeholder stock before rate cuts come: https://www.marketbeat.com/logos/articles/med_20240102190745_att-could-be-the-best-placeholder-stock-before-rat.jpg
AT&T could be the best placeholder stock before rate cuts come

A significant shift is about to come to the financial markets, as the forces that push and pull stock prices are pivoting from one end to the opposite in the coming months. Interest rates act as a

Will cost cuts be enough for Hasbro to thrive in 2024?: https://www.marketbeat.com/logos/articles/med_20231231120706_chartt-has.jpg
Will cost cuts be enough for Hasbro to thrive in 2024?

Global toy and entertainment company Hasbro Inc. (NYSE: HAS) had a weak 2023 as shares fell 17.5% compared to the 24.8% gain for the S&P 500 index. It also underperformed rival Mattel Inc. (NYSE:

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205: https://www.irw-press.at/prcom/images/messages/2024/73150/Aktiencheck030124.001.png
Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Massives Kaufsignal. 297% Biotech Aktientip nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205

Eilt: Biotech Hot Stock 2024 heilt Hautkrebs vollständig - Kaufsignal. 297% Biotech Aktientip nach 15.973% mit BioNTech

 

03.01.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Link

Analysts suddenly say Google is the place to be in: https://www.marketbeat.com/logos/articles/med_20240102074605_analysts-suddenly-say-google-is-the-place-to-be-in.jpg
Analysts suddenly say Google is the place to be in

Very few times in history have investors come across a stock that offers the sort of moat that Warren Buffett could salivate over, a strong business with solid financials and a structure

One fast-food stock is expected to outperform all others in 2024: https://www.marketbeat.com/logos/articles/med_20240102074256_one-fast-food-stock-is-expected-to-outperform-all.jpg
One fast-food stock is expected to outperform all others in 2024

With a 20% rally under its belt since October, it goes without saying that McDonald's Corp (NYSE: MCD) is coming into 2024 looking pretty hot. After a disappointing Q3 threatened to spiral out of

PepsiCo's dividend won't last long in today's market: https://www.marketbeat.com/logos/articles/med_20240101143450_pepsicos-dividend-wont-last-long-in-todays-market.jpg
PepsiCo's dividend won't last long in today's market

Markets shift according to a straightforward selection process; as money becomes interested in better instruments or investments, money as a whole begins to rotate into different areas of the

4 reasons to buy Dutch Bros stock over Starbucks: https://www.marketbeat.com/logos/articles/med_20231231121354_chart-bros2.jpg
4 reasons to buy Dutch Bros stock over Starbucks

Drive-thru coffee and beverage operator Dutch Bros Inc. (NASDAQ: BROS) stock has more upside than the incumbent behemoth Starbucks Co. (NASDAQ: SBUX) on a percentage basis. Its newly minted CEO

New price targets could erase Cisco's 3.1% dividend yield soon: https://www.marketbeat.com/logos/articles/med_20240101140630_new-price-targets-could-erase-ciscos-3.jpg
New price targets could erase Cisco's 3.1% dividend yield soon

A new FED has come into play to end 2023 with a major surprise for most investors out there trying to find a direction to bet on and the implications this new view has are plenty, but today, you

Is the Apple Watch ban the tipping point?: https://www.marketbeat.com/logos/articles/med_20231231120446_chartt-aapl.jpg
Is the Apple Watch ban the tipping point?

Apple Inc. (NYSE: AAPL) had a stellar 2023, gaining 49.39% for 2023 while maintaining the largest weighting in the S&P 500. While the technology sector juggernaut continues to grow, its sales have

3 mega caps with RSIs that point to big Q1s: https://www.marketbeat.com/logos/articles/med_20231229111505_3-mega-caps-with-rsis-that-point-to-big-q1s.jpg
3 mega caps with RSIs that point to big Q1s

With the S&P 500 index on the verge of hitting an all-time high and many others already there, it's no surprise that investors are enjoying strong year-end rallies. Indeed, all signs point to 2023

Celsius stock in actionable zone as big investors ramp up buying: https://www.marketbeat.com/logos/articles/med_20231229104624_celsius-stock-in-actionable-zone-as-big-investors.jpg
Celsius stock in actionable zone as big investors ramp up buying

Energy drink maker Celsius Holdings Inc. (NASDAQ: CELH) has been a fast mover since its 2017 IPO and may offer an early buy opportunity. 

The Celsius chart shows the stock consolidating above its

Microsoft is new cybersecurity titan, challenging big tech rivals: https://www.marketbeat.com/logos/articles/med_20231229082948_microsoft-is-new-cybersecurity-titan-challenging-b.jpg
Microsoft is new cybersecurity titan, challenging big tech rivals

You might not think of Microsoft Corp. (NASDAQ: MSFT) as a leader in the cybersecurity space, but the company has been making big strides in that part of the tech industry. 

As with many business

Synopsys stock: Unsung hero of the AI revolution: https://www.marketbeat.com/logos/articles/med_20231229073521_synopsys-stock-unsung-hero-of-the-ai-revolution.jpg
Synopsys stock: Unsung hero of the AI revolution

Synopsys Inc. (NASDAQ: SNPS), maker of semiconductor design software, created a buzz recently when it offered to buy engineering software maker Ansys Inc. (NASDAQ: ANSS).

Synopsys isn’t a

Apple stock is institutional favorite, but is it overvalued?: https://www.marketbeat.com/logos/articles/med_20231229072720_apple-stock-is-institutional-favorite-but-is-it-ov.jpg
Apple stock is institutional favorite, but is it overvalued?

With Apple Inc. (NASDAQ: AAPL) holding the No. 1 spot as the biggest S&P 500 component, and having posted a 2023 gain of 49.39% is the stock overvalued, or primed for a correction in 2024? 

Even

Four beaten-down penny stocks ready to take off: https://www.marketbeat.com/logos/articles/med_20231228125201_chart-lazr-12282023ver001.png
Four beaten-down penny stocks ready to take off

Penny stocks are attractive simply because of the opportunity for exponential returns. Stocks like Alphabet Inc. (NASDAQ: GOOG), Microsoft Corporation (NASDAQ: MSFT) and Apple Inc. (NASDAQ: AAPL)

Eilt: Biotech Hot Stock heilt Hautkrebs vollständig - Massives Kaufsignal. Diese Biotech-Aktie jetzt kaufen nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2023/73132/AC01-29-23_AC1.001.png
Eilt: Biotech Hot Stock heilt Hautkrebs vollständig - Massives Kaufsignal. Diese Biotech-Aktie jetzt kaufen nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Biotech Hot Stock heilt Hautkrebs vollständig - Kaufsignal. Diese Biotech-Aktie kaufen nach 15.973% mit BioNTech

 

29.12.23 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

If you buy the dogs, should you sell these Dow leaders?: https://www.marketbeat.com/logos/articles/med_20231228074608_chart-intc-12282023ver001.png
If you buy the dogs, should you sell these Dow leaders?

The Dogs of the Dow is a popular strategy getting much attention now that the year-end is here. The theory assumes that this year’s losers will be next year’s winners, which is often true. Dow

Ray Dalio keeps adding to this ETF, what's he thinking?: https://www.marketbeat.com/logos/articles/med_20231228072323_ray-dalio-keeps-adding-to-this-etf-whats-he-thinki.jpg
Ray Dalio keeps adding to this ETF, what's he thinking?

Last quarter, it became evident to thousands of investors just like you just how bullish Ray Dalio had become on Asian markets. Still, while most thought it was a one-time allocation to gain the

2 Tech stocks getting bullish upgrades ahead of Q1: https://www.marketbeat.com/logos/articles/med_20231228073315_2-tech-stocks-getting-bullish-upgrades-ahead-of-q1.jpg
2 Tech stocks getting bullish upgrades ahead of Q1

There’s no doubt about it: equities have had a super strong end to the year, with the Dow Jones index already at fresh all-time highs and the others on its heels. The benchmark S&P 500 index, for

What to expect from the Q1 earnings reporting cycle: https://www.marketbeat.com/logos/articles/med_20231227123634_chart-spy-12272023ver001.png
What to expect from the Q1 earnings reporting cycle

The New Year is almost upon us and, with it, the next earnings reporting cycle. The calendar Q1/fiscal Q4 cycle is expected to bring another quarter of growth for the S&P 500 (NYSEARCA: SPY) and

If Ray Dalio took profits here, then this stock needs to catch up: https://www.marketbeat.com/logos/articles/med_20231227200044_if-ray-dalio-took-profits-here-then-this-stock-nee.jpg
If Ray Dalio took profits here, then this stock needs to catch up

If there is one thing that investors need help getting used to, it is learning where - and where not - to take cues for potentially better places to invest when they come up. Many "experts" are

3 tech stocks on the verge of major breakouts: https://www.marketbeat.com/logos/articles/med_20231227192924_3-tech-stocks-on-the-verge-of-major-breakouts.jpg
3 tech stocks on the verge of major breakouts

As we near the year's end, the technology sector is concluding on an impressive note, having recently reached new all-time highs. The tech sector has taken the lead throughout the year, outpacing

Eilt: Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. Massives Kaufsignal. Diesen 359% Biotech Hot Stock jetzt kaufen nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.: https://www.irw-press.at/prcom/images/messages/2023/73122/AC12-28-23AC1.001.png
Eilt: Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. Massives Kaufsignal. Diesen 359% Biotech Hot Stock jetzt kaufen nach 134.452% mit Biogen. Massives Kaufsignal. Jetzt 359% mit Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.

Eilt: Biotech Hot Stock erzielt Durchbruch im Kampf gegen Hautkrebs. 359% Biotech Aktientip nach 134.452% mit Biogen

 

28.12.23 08:02

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

Are high-yield Dow Dogs a good buy for 2024?: https://www.marketbeat.com/logos/articles/med_20231227102631_chart-vz-12272023-002ver001.png
Are high-yield Dow Dogs a good buy for 2024?

The Dogs of the Dow theory assumes that this year’s worst performers will be the best-performing stocks in the next. If not, they should provide solid rebounds due to their “lower” value, and many